Kent: This is translational medicine at its best. It's realizing that a dog with a disease that naturally occurs is very similar to a human with the disease and we do have less regulation but we do put ourselves in the same kind of strict requirements that are required for a human trial and to make sure that it's safe to give to our patients.
Narrator: Kent has just completed the first phase of a trial with dogs, testing safety levels of the drug.
Kent: It's so vital that we take what's learned in the basic science side and learn to apply it to our patients. It benefits my patients in being able to get these drugs that will not be available for years for people, but allows me to try them now and hopefully benefit my patients in the process.Narrator: For Science Today, I'm Larissa Branin.